P3.02-018 Patients Harboring ALK Rearrangement Adenocarcinoma after Acquired Resistance to Crizotinib and Transformation to SCLC: A Case Report

Authors :: You-cai Zhu
Kai-qi Du
W. H. Wang
Ying Chen
M. Fang
R. Chen
Wu Zhuang
X. Liao
C. Xu
Gongyan Chen
Source :: Journal of Thoracic Oncology. 12:S2244
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Pulmonary and Respiratory Medicine
Transformation (genetics)
Acquired resistance
Oncology
Crizotinib
business.industry
medicine
Cancer research
Adenocarcinoma
ALK Rearrangement
medicine.disease
business
medicine.drug

Full Text Access

Tools